Tectonic Therapeutic, Inc. — Director's Dealing 2022

Dec 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2022-12-08

Reporting Person: Avruch Steven (Chief Legal Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-08	Stock Option (Right to Buy)	$.79	A	169500	Acquired	2032-12-07	Common Stock (169500)	Direct

Footnotes

F1: 50% of the shares shall vest and become exercisable on the first anniversary of the grant date, and the remaining 50% shall vest in equal monthly installments thereafter over a one-year period.